Cargando…

Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS

BACKGROUND AND OBJECTIVES: Current scales used in amyotrophic lateral sclerosis (ALS) attempt to summarize different functional domains or “dimensions” into 1 overall score, which may not accurately characterize the individual patient's disease severity or prognosis. The use of composite score...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jongh, Adriaan D., van Eijk, Ruben P.A., Bakker, Leonhard A., Bunte, Tommy M., Beelen, Anita, van der Meijden, Conny, van Es, Michael A., Visser-Meily, Johanna M.A., Kruitwagen, Esther T., Veldink, Jan H., van den Berg, Leonard H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424842/ https://www.ncbi.nlm.nih.gov/pubmed/37311649 http://dx.doi.org/10.1212/WNL.0000000000207483

Ejemplares similares

Implementation and evaluation of an e-health innovation for personalized care for patients with amyotrophic lateral sclerosis (ALS): protocol for a participatory action research study
por: Dontje, M. L., et al.
Publicado: (2021)

Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide
por: van Eenennaam, Remko M., et al.
Publicado: (2020)

Parental and child adjustment to amyotrophic lateral sclerosis: transformations, struggles and needs
por: Sommers-Spijkerman, Marion, et al.
Publicado: (2022)

Discussing Personalized Prognosis Empowers Patients with Amyotrophic Lateral Sclerosis to Regain Control over Their Future: A Qualitative Study
por: van Eenennaam, Remko M., et al.
Publicado: (2021)

Control in the absence of choice: A qualitative study on decision-making about gastrostomy in people with amyotrophic lateral sclerosis, caregivers, and healthcare professionals
por: van Eenennaam, Remko M., et al.
Publicado: (2023)

Caregiver burden in amyotrophic lateral sclerosis: A systematic review
por: de Wit, Jessica, et al.
Publicado: (2017)

The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral Sclerosis
por: Tan, Harold H. G., et al.
Publicado: (2020)

Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study
por: Janse van Mantgem, Mark R., et al.
Publicado: (2023)

Pattern of muscle strength improvement after intravenous immunoglobulin therapy in multifocal motor neuropathy
por: Bakers, Jaap N.E., et al.
Publicado: (2021)

Evaluation of the nation-wide implementation of ALS home monitoring & coaching: an e-health innovation for personalized care for patients with motor neuron disease
por: Dontje, M. L., et al.
Publicado: (2022)

Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance
por: Fortuna, Andrea, et al.
Publicado: (2022)

Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study
por: van Eijk, Ruben P. A., et al.
Publicado: (2019)

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019)

Correction to: Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance
por: Fortuna, Andrea, et al.
Publicado: (2023)

The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)
por: Mul, Karlien, et al.
Publicado: (2021)

Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis
por: van der Burgh, Hannelore K., et al.
Publicado: (2020)

User perspectives on a psychosocial blended support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: a qualitative study
por: de Wit, Jessica, et al.
Publicado: (2019)

Longitudinal comparison of the self‐entry Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised (ALSFRS‐RSE) and Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis
por: Johnson, Stephen A., et al.
Publicado: (2022)

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2018)

Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands
por: de Jongh, Adriaan D., et al.
Publicado: (2021)

A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial
por: de Wit, Jessica, et al.
Publicado: (2018)

Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study
por: van Rheenen, Wouter, et al.
Publicado: (2018)

Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model
por: Bakker, Leonhard A., et al.
Publicado: (2017)

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2017)

UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
por: Willemse, Sean W, et al.
Publicado: (2023)

Rasch-Built Measure of Pleasant Touch through Active Fingertip Exploration
por: Klöcker, Anne, et al.
Publicado: (2012)

Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)
por: Keh, Ryan Yann Shern, et al.
Publicado: (2022)

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
por: Taskesen, E., et al.
Publicado: (2017)

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021)

Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
por: Taskesen, E., et al.
Publicado: (2018)

Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale
por: Hermans, Mieke C. E., et al.
Publicado: (2015)

Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review
por: van Groenestijn, Annerieke C., et al.
Publicado: (2016)

Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
por: Merkies, Ingemar S. J., et al.
Publicado: (2022)

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
por: McLaughlin, Russell L., et al.
Publicado: (2017)

Portable fixed dynamometry: towards remote muscle strength measurements in patients with motor neuron disease
por: Bakers, Jaap N. E., et al.
Publicado: (2020)

Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand
por: van Eijk, Ruben P.A., et al.
Publicado: (2022)

Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases
por: Helleman, Jochem, et al.
Publicado: (2020)

Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis
por: van Eijk, Ruben PA, et al.
Publicado: (2018)

Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
por: Nitert, Abram D, et al.
Publicado: (2022)

No association between gluten sensitivity and amyotrophic lateral sclerosis
por: Visser, Anne E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aic78vq2jnm6h7dv5h5ctgdpnd